GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
USA - NASDAQ:GDRX - US38246G1085 - Common Stock
4.53 USD
+0.04 (+0.78%)
4.55 USD
+0.02 (+0.44%)
We assign a fundamental rating of 5 out of 10 to GDRX. GDRX was compared to 35 industry peers in the Health Care Technology industry. GDRX has an average financial health and profitability rating. GDRX may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make GDRX suitable for value investing!
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
GDRX had a positive operating cash flow in the past year.
In the past 5 years GDRX reported 4 times negative net income.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 2.62%, GDRX belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
GDRX has a Return On Equity of 5.38%. This is amongst the best in the industry. GDRX outperforms 91.43% of its industry peers.
GDRX has a better Return On Invested Capital (5.90%) than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROIC | 5.9% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 4.33%, GDRX belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Profit Margin of GDRX has declined.
Looking at the Operating Margin, with a value of 11.10%, GDRX belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
GDRX's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 93.68%, GDRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GDRX has less shares outstanding
Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
The debt/assets ratio for GDRX has been reduced compared to a year ago.
2.2 Solvency
GDRX has an Altman-Z score of 1.09. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.09, GDRX perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
GDRX has a debt to FCF ratio of 4.14. This is a neutral value as GDRX would need 4.14 years to pay back of all of its debts.
With a Debt to FCF ratio value of 4.14, GDRX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
A Debt/Equity ratio of 0.75 indicates that GDRX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.75, GDRX is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Altman-Z | 1.09 |
ROIC/WACC0.57
WACC10.34%
2.3 Liquidity
A Current Ratio of 4.21 indicates that GDRX has no problem at all paying its short term obligations.
The Current ratio of GDRX (4.21) is better than 85.71% of its industry peers.
GDRX has a Quick Ratio of 4.21. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.21, GDRX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
Measured over the past years, GDRX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.47% on average per year.
The Revenue has been growing slightly by 3.19% in the past year.
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
3.2 Future
GDRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.30% yearly.
The Revenue is expected to grow by 5.48% on average over the next years.
EPS Next Y15.54%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.94 indicates a correct valuation of GDRX.
Based on the Price/Earnings ratio, GDRX is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of GDRX to the average of the S&P500 Index (27.86), we can say GDRX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.81, the valuation of GDRX can be described as reasonable.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaper than 94.29% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.32. GDRX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.94 | ||
| Fwd PE | 9.81 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 85.71% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GDRX is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.3 | ||
| EV/EBITDA | 10.67 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GDRX may justify a higher PE ratio.
A more expensive valuation may be justified as GDRX's earnings are expected to grow with 16.99% in the coming years.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y18.32%
EPS Next 3Y16.99%
5. Dividend
5.1 Amount
No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.53
+0.04 (+0.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners58.63%
Inst Owner Change-2.03%
Ins Owners11.85%
Ins Owner Change7.93%
Market Cap1.57B
Analysts75.45
Price Target5.43 (19.87%)
Short Float %6.82%
Short Ratio1.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.88%
Min EPS beat(2)-10.65%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-10.65%
Max EPS beat(4)-7.12%
EPS beat(8)3
Avg EPS beat(8)-2.89%
EPS beat(12)7
Avg EPS beat(12)10.95%
EPS beat(16)10
Avg EPS beat(16)12.15%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.55%
Revenue beat(12)1
Avg Revenue beat(12)-1.8%
Revenue beat(16)2
Avg Revenue beat(16)-1.63%
PT rev (1m)0%
PT rev (3m)-15.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.81%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-3.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.94 | ||
| Fwd PE | 9.81 | ||
| P/S | 1.97 | ||
| P/FCF | 13.3 | ||
| P/OCF | 8.25 | ||
| P/B | 2.45 | ||
| P/tB | 90.15 | ||
| EV/EBITDA | 10.67 |
EPS(TTM)0.35
EY7.73%
EPS(NY)0.46
Fwd EY10.2%
FCF(TTM)0.34
FCFY7.52%
OCF(TTM)0.55
OCFY12.13%
SpS2.3
BVpS1.85
TBVpS0.05
PEG (NY)0.83
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| ROCE | 7.47% | ||
| ROIC | 5.9% | ||
| ROICexc | 7.74% | ||
| ROICexgc | 24.97% | ||
| OM | 11.1% | ||
| PM (TTM) | 4.33% | ||
| GM | 93.68% | ||
| FCFM | 14.8% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.95%
ROICexcg growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.75 | ||
| Debt/FCF | 4.14 | ||
| Debt/EBITDA | 2.92 | ||
| Cap/Depr | 93.99% | ||
| Cap/Sales | 9.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 115.02% | ||
| Profit Quality | 342.04% | ||
| Current Ratio | 4.21 | ||
| Quick Ratio | 4.21 | ||
| Altman-Z | 1.09 |
F-Score8
WACC10.34%
ROIC/WACC0.57
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
EPS Next Y15.54%
EPS Next 2Y18.32%
EPS Next 3Y16.99%
EPS Next 5Y24.3%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
Revenue Next Year0.65%
Revenue Next 2Y2.95%
Revenue Next 3Y4.51%
Revenue Next 5Y5.48%
EBIT growth 1Y407.89%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year32.27%
EBIT Next 3Y16.67%
EBIT Next 5Y12.79%
FCF growth 1Y70.28%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y49.36%
OCF growth 3Y0.94%
OCF growth 5Y17.16%